Search the KHIT Blog

Sunday, August 16, 2015

"Personalized Medicine" - will Health IT be up to the task?

Bought this book yesterday morning, and read it straight through, it was so compelling.
...“[A]dverse drug reactions” are common: every year more than 2 million North Americans are hospitalized because of adverse reactions to prescription drugs. The reason why drugs work in some people and cause bad reactions in others can usually be traced back to differences in genetic makeup. Medicines that work for most people may not work for you. They may, indeed, harm you. So we need two things: first, we need ways of predicting and detecting disease well before it becomes life threatening; and second, we need medicines that work for you and your unique body.

Medicine has been trying to do these two things for millennia. While enormous progress has been made, it is still not good enough. And so it is that we are nearing the biggest revolution of our time — perhaps of all time.

This revolution has many names and guises. It is sometimes called personalized medicine, sometimes precision medicine, sometimes stratified medicine. It is a cousin of “evidence-based” medicine, a relatively new concept in medical practice. (Whoever came up with that name was clearly trying to make a point.) Whatever the name, what we will call personalized medicine — medicine based on the unique molecular makeup of our individual selves and a molecular-level understanding of whatever disorder we may have — is on our doorsteps...

Medical progress to this point has been mainly based on advances that benefit the population as a whole rather than you as an individual...

[A] family practice physician, on being asked how he selects the best drug for patients suffering from depression, answered, “Well, I have a dartboard hanging behind my door. It depends what number I hit.” There is no way for him to know in advance which drug will work best for which patient and which patient will suffer a nasty side effect. And so the patient and the doctor embark on a risky trial-and-error journey to find the best, most effective drug for him or her...

Your doctor sees the macroscopic version of you and, on the basis of a physical examination and your symptoms, can often diagnose what is wrong quite efficiently. But your doctor does not know much about the microscopic version of you, where disease and your responses to treatment are first manifested.

Your doctor does not know details of your genetic code and therefore cannot know how you will respond to a drug he or she may prescribe. Your doctor does not know the composition of molecules in your blood, which contain a huge amount of diagnostic information regarding diseases that you may have or be trending towards, whether the drugs you are taking are working to cure whatever disorder you are suffering from, or whether your diet is appropriate. Your doctor does not know the types and amounts of micro-organisms that are living in you and on you, which influence how well your immune system is working and play important roles in inflammatory diseases. In short, your doctor does not have access to a lot of important molecular-level information about you to guide many of his or her decisions. This can lead to wrong or delayed diagnoses and inappropriate therapeutic interventions.

The medicine of the future will be more personalized — and much more effective — because detailed molecular-level information about you and whatever disorder you may have is increasingly available...

This future is not very far away. [Kindle locations 44-147]
A great read. At once informed, erudite, accessible, ethically introspective, and genial. Dr. Cullis has considerable cred.

A nice follow-on perspective to this one I'd first cited in a prior post back in May.


I then cited "Biocode" again in my July 16th post "Personalized Medicine" and "Omics" -- HIT and QA considerations.

Let me return for my core concerns aired a month ago: 
I have a couple of concerns. Docs often don’t have enough time TODAY to get through an electronic SOAP note effectively, given workflow constraints. Adding in torrents of “omics” data may be problematic, both in terms of the sheer number of additional potential dx/tx variables to be considered in a short amount of time, and questions of “omics” analytic competency. To that latter point, what will even constitute dx "competency" in the individual patient dx context, given the relative infancy of the research domain? (Not to mention issues of genomic lab QC/QA -- a particular focus that I will have, in light of my 80's lab QC background).
President Obama’s current infatuation with “Precision Medicine” notwithstanding, just dumping a bunch of “omics” data into EHRs (insufficiently vetted for accuracy and utility, and inadequately understood by the diagnosing clinician) is likely to set us up for our latest HIT disappointment -- and perhaps injure patients in the process.
apropos, Dr. Cullis, Chapter 5:
THE TIPPING POINT, where medical practice will suddenly adopt the principles of personalized medicine, will be reached within the next five years. You will experience a memorable personal tipping point when you first get your genome sequenced, your microbiome analyzed, your metabolome assayed, and your proteome measured and then sit down with your doctor or wellness coach to discuss the implications of this very definitive data that is all about you. The data will be so precise and all-encompassing that it will show not only what may be wrong with you but also what you ate for breakfast yesterday and what type of dog you own. The impact of this information on you and the way you live your life will be greater than any other technological advance you have ever experienced. Remember when you started using Google and suddenly had access to all the information in the world and couldn’t imagine how you operated before? Or, for those who are old enough, remember the feeling you had when you started using email and suddenly had immediate communication with all parts of the world, for free? Or, for those of you who are really old, the first time you realized that having your own computer could actually be useful? Or, for those of you who, like the author, are positively ancient, the time you picked up your first hand-held calculator that could multiply and divide and take square roots? Well the personalized medicine revolution will trump them all.

The harbingers of the revolution are all around us.

Early versions of the digital version of you are starting to appear, although progress has been slow because of the enormous institutional, technical, and societal issues involved. The deeply conservative instincts of the medical profession have not helped either. The first manifestation of the digital you is (or will be) your electronic medical record (EMR) sometimes known as your electronic health record (EHR). The first attempts to introduce EMRs date back to the late 1960s; in the 1970s, the Department of Veterans Affairs had a working Computerized Patient Record System that established the ability of EMRs to reduce medical errors. Problems ranging from lack of standards, security concerns, and aversion to change prevented general adoption of EMRs until, with some frustration, President Obama pushed the Health Information Technology for Economic and Clinical Health Act into law in 2009. The legislation mandated a transition to EMRs for physicians and hospitals that treat patients covered by government insurance.

Still, it is surprising that in the U.S. in 2012 (the latest year for which records are available), only 72 percent of physicians used any form of electronic health record, ranging from just 54 percent in New Jersey to 89 percent in Massachusetts. In 2009, only 48 percent of physicians used EMRs. And right now, EMRs are not all that complicated. They consist of a digital store of your complete medical history, including medications and allergies, immunization status, laboratory test results, radiology images, vital signs, and personal statistics like age and weight. The lack of EMRs has meant untold duplication, errors due to incomprehensible handwriting, lack of knowledge about pre-existing conditions, and ongoing patient frustration with doctors who refuse to enter the digital age that the rest of us embraced twenty years ago. How many times have you been referred to a doctor, only to be asked the same questions all over again or be required to do a test that you’ve already done, simply because the doctor has no access to an electronic version of your medical history?

Some of the reasons for delay, it has to be admitted, are not the fault of the medical profession. Privacy is an enormous Your EMR, because it is in electronic form, is susceptible to the same sort of hacking as any other personal data stored on your computer or by your credit card company or by your bank. Clearly you don’t want an insurer or employer to get hold of your medical record without your authorization. But if your bank can achieve a secure online system for you to conduct your financial transactions, why can’t one be created for your medical information? Regardless, the digitization dam that’s been holding back universal EMRs has clearly burst, and we are finally entering the digital age of medicine.

Assuming you have one, can you get hold of your own electronic medical record? You should be able to — after all, it’s all about you. But ownership can be complicated, and doctors who have purchased an EMR system may feel that information in it about you belongs to them. Often, a strange distinction exists: the doctor or hospital owns your medical record, but you own the data in your medical record. In any event, if your medical record is digitized, you should be able to get hold of a digital copy.

The next step will be to add your genomic, proteomic, microbiomic, and all the other data to your EMR to achieve a more complete digital version of yourself. Early signs of development of such personalized data clouds and their utility are being seen for a small number of individuals who have access to the sophisticated resources currently required in order to study themselves in detail at the molecular level... [op cit, Kindle Locations 882-920].
"The next step will be to add your genomic, proteomic, microbiomic, and all the other data to your EMR to achieve a more complete digital version of yourself." 
Yeah, OK, but we can't even get our wailing incumbent EHR vendors to agree to comply en masse with the functionally feeble Meaningful Use Stage 3 specs.

Then there's the issue of "omics" analytic competency.
So, you say, “That’s good so far, very impressive. I can see how we’ll generate all this information and store it, but you still haven’t told me how I’m going to use this damn data to prevent or cure my disease or make myself feel better.” Ah, yes — slight problem there. That’s where the bottleneck is, and any readers who want a well-paid, highly secure occupation for the next twenty years should become experts in bioinformatics, particularly as it pertains to interpreting the large datasets surrounding genomic, proteomic, and other “omic” information... [ibid, Kindle Locations 793-797].
Beyond the requisite Omics dx acumen (in short supply), I remain skeptical regarding the notion of adding "your genomic, proteomic, microbiomic, and all the other data to your EMR."

For one thing, we think we're having "interoperability" problems now? Lordy.

UPDATE: AN ADMONITION FROM ANOTHER SOURCE

The use of genomic sequence data in a clinical setting is truly a new phenomenon in this 21st century. In the year 1999, no human had ever had their genomes sequenced; by 2009 there were seven individuals who it had their genomes sequenced, and it has been predicted by some that the millionth person will have their genome sequenced in calendar year 2014. Although it is not clear if or when the remarkable uptake of this technology might level off, it is clear that this technology will increasingly affect the way medicine is practiced. All healthcare practitioners will be increasingly asked to put this [sic] data into an appropriate clinical context.

Genomics has the potential to improve our approach to care in almost every aspect of medicine from cancer to infectious diseases.

We are moving into an increasingly DNA–first world of clinical medicine, where DNA sequence data will be available for decision-making prior to the patient’s visit to your office or hospital. In this DNA – first world, we will all need point of care decision support and we hope in these early years of genomic medicine you will find this book to be useful in your decision support needs.

Importantly, enthusiasm about genomic medicine should not lead to an abandonment of the classic tools of clinical medicine that are needed to inform care. First and foremost among these tools are the history and physical examination. The importance of environmental influences on health must not be overlooked. While this text gives great attention to the “nature” side of the nature versus nurture equation, there are many other sources of important information on the role of environment in all diseases including that which is considered as “genetic”.

The evolving role for family health history

Family health history has been used in clinical medicine for generations as a proxy for genetic information in efforts to protect disease risk in patients. In contrast to its previous application, in the era of DNA–first genomic medicine, family health history will increasingly be used to add context to the DNA Since every patient will be revealed to have rare genetic changes, so rare that they may only exist within their immediate family, the health history of others in the family who share these changes will be necessary in order to gain insight into how these changes will affect health. It will only be through knowing how these changes played out for the patient’s immediate relatives that we will be able to interpret some sequence variations in the patient who is being seen. It is because of this “interpretive need” that we will ultimately require detailed family histories that are annotated with DNA sequence variant information...
I haven't bought this book. Yet. I may. I used Dragon to talk the foregoing excerpt in.

It's rather expensive. But, if you surf through the Amazon Preview chapter topic listings, you can see how a clinician would find it useful. A principal takeaway for me is that a truly effective "genetic counselor" might also have to be an MD. And, we might ask, will such "Omics" curricula become a requisite component of physician training -- or, will it become the domain of yet another specialty subset (or, more troubling, some sub-MD pay-to-play "online certificate" or otherwise for-profit diploma-mill holder)? I seriously doubt that my urologist did anything other than take my OncoType dx genetic assay prostate cancer report at face value.

Just like my RadOnco docs likely (necessarily) did little to nothing beyond reading the radiologists' "impression" narrative summaries for my CT, MRI, and bone scans.
__

"The next step will be to add your genomic, proteomic, microbiomic, and all the other data to your EMR"

Yeah, but, beyond workforce capacity and dx acumen, what about the chronic, persistent data silo/opacity issue? A recent THCB post asks
What’s the Definition of Interoperability?
Seriously? We already have it. The IEEE definition. As I commented at THCB:
We already HAVE a concise definition of “interoperability," via the IEEE, “interoperability: Ability of a system or a product to work with other systems or products without special effort on the part of the customer. Interoperability is made possible by the implementation of standards.”

This other stuff is merely about “data exchange.” What is happening is that we’re “defining interoperability down,” removing the “without special effort” part. Were there a Data Dictionary Standard, then we could talk about interoperability. Data are called “the lifeblood of health care.” Fine. Think Type-O, the universal blood type, by way of precise analogy.

Maybe the API will comprise data exchange salvation. Maybe.
Responding to the interviewee in the THCB post, I quoted him and offered a response.
“One of the key ways we build good support systems is by having good data. It’s a “garbage in – garbage out” problem. One can’t make good decisions without good data. One of the problems is that a lot of the time data exists but it isn’t in the computer or isn’t in MY computer. Maybe someone has had a test somewhere else and I might not have any info, or if I’m lucky I might have a scanned PDF of the results. But it’s rarer still that I’ll have good, structured data that I’ve been able to pull in from outside sources without a lot of transcription or effort. So I became very interested in this problem of interoperability and have been doing a range of different kinds of work. Some of it actually focuses on how you do decision support, in the cloud or across systems. So the question becomes: how can you build a decision support system that spans several electronic health records and integrated data from multiple sources to make more accurate suggestions for patient care?”
__

By having a comprehensive standard data dictionary. Absent that, you have to have “n” variables x n(n-1) translative “interfaces” (if you’re after computable “structured data” rather than document-centric reports).
It's an excellent post, albeit replete with the usual obtuse "interoperababble" we have all come to know and love. On the upshot of Meaningful Use:
[Adam Wright] We were going to create these strong incentives for people to adopt EHR’s, knowing that EHR’s were not yet perfectly interoperable or even always perfectly usable and didn’t have all the functionality that we wanted. And now we’re trying to go back and patch that. The thing is we now have had a lot of opportunity to learn how, with these EHR’s that were developed with large hospitals or academic systems in mind, how do they really work in critical access hospital or in a single doctor practice. So we’ve learned, and I think the key is going to be to translate what we’ve learned into concrete improvements. But I think that’s been hard. I talk to some of my friends who are vendors and they’ve said “A lot of people are giving us feedback and we’re working on it as fast as we can but at the same time we’re getting a lot of pressure from Meaningful Use. So we can’t even use our best developers to build the stuff our customers are asking for asking for.” So I think some way of fixing how we do innovation in health IT is going to be important and I don’t know how exactly how we’ll do it, given how many competing priorities there are.
Indeed. Nicely stated. More Adam Wright:
I absolutely think that seeing a complete picture of a patient’s information is key for safety and I do think that lack of interoperability is 100% a safety issue. It’s something that we need to work on. But we need to get beyond the “unconscious patient in Wyoming.” I think that there’s so many more complex, subtle and insidious issues. The thing is that it’s often hard to measure. It’s hard to say “this is the one piece of information that changed my mind”. But I do think complete information like that is going to be very important. I’ll also offer you a flip side that I don’t really have an answer for yet: How much information am I responsible for viewing about a patient? Somehow I now have every piece of information about a patient from the moment of birth to the present. That might be more information than I can review before my brief visit with a patient. Part of the solution to that is going to be in technology or tools that will help me summarize the information, spot key information, spot trends etc. I think it’s going to be really exciting when we have that problem and have to build those tools. I look forward to the day when we have so much information that we really need sophisticated tools to organize and sort through it. Right now we’re a long way from that. But I think you’re 100% right that it’s a safety issue.
Interesting. Some of that maps right back to the "omics" concerns set forth above.

At the conclusion of the THCB post:
LK: So the last question is something Dan Monro brought up. Dan did a three-part series on interoperability on the site I write for called HL7 Standards.com. Essentially if you don’t have a patient identifier, then interoperability is a waste of time. He alluded to the idea of patient identifiers being something like a social security number in that they’re kind of old-school. There’s better ways to do it with cryptography and being able to ID people biometrically. So what can you tell us about patient identifiers? 

AW: I think it’s awfully important. It’s certainly the case that when I have a database and you have a database and we want to link them together, it matters that we have a key so that we can tell who is the same person. The approach right now with using a social security number has problems. Not everyone always has a SSN, not everyone remembers them, there are errors, they lack any way to validate them, etc. Using something like your Blue Cross member number is no good either because you can get another job. So I think the solutions we have now are rotten. We need some way to identify patients across systems. The most commonly proposed, and probably simplest or most parsimonious solution, is a national patient identifier. A numerator who sits in the government and assigns everyone a number shortly after birth and that’s their number. That is just not going to fly palatably. I just can’t see us creating the political will and I also am not sure that it is that desirable. Travelers could come to the country and not have numbers or Americans can go elsewhere and how will this all work? It seems problematic. But I think there are smart ways we could use technology to approximate that. For a long time we had probabilistic record linking approaches where we look at your name, date of birth, address, age, sex, etc. and try to figure out what is the probability that these two people are the same, and we’ve had some pretty good results. The Indianapolis Network for Patient Care has had some pretty good results there, using probabilistic linking rather than an identifier. The reality is that if we can put the patient at the center of this and creates a credential and authentication that they control, I think that would be a lot more palatable than if we put some sort of central government number assigned to people...
Well, yeah, a "national patient identifier" seems to be a non-starter, and multi-field proxy keys seem to be the only practical work-arounds. Adam sums up:
I think there’s probably a lot we can learn from internet authentication about how to create reliable patient identifiers with creating better identifiers, more security around them. The patient could see more of their information and how it was shared. I just think that there are better solutions than a single government based national patient identifier. And even if it’s the best solution, I just don’t think it’s politically possible. So I think we ought to be focusing our efforts on something else.
For more on this line of thought, and the "EXTREME" interop model, see "Defining Our Terms: Does Anyone Know What an "Open EHR" Really Is?"

SO, WHAT MIGHT COMPRISE THE "SOMETHING ELSE"?

Enter the "cryptocurrency" model?


WHAT!? you say? Stay with me.

to wit, "YouBase."


For those who really want to get their geek on.
Abstract
YouBase enables individuals to create and maintain a personal data store on a distributed public network, allowing the unprecedented ability to easily gather, analyze, and share private data for any purpose imaginable. Data is structured hierarchically so that increasingly identifiable data can be placed at levels closer to the root, allowing arbitrarily anonymized data to be shared with whomever is requesting access to it. The data format is flexible, enabling easy integration with third parties. In addition, read-only or read/write access can be granted at any node in the tree, allowing the user to tightly control access to every subtree in the data store. YouBase thus provides the building blocks for the ultimate peer-to-peer central repository for private data, enabling individuals, organizations, and the world to make smarter decisions.

Introduction

Cryptography combined with distributed applications and databases in peer-to-peer networks provide the fundamental building blocks required for securing stores of individual-centered digital property in an open standards-based manner. By using encryption, digital signatures, digital wallets, and distributed data, ownership of digital information can be managed in a decentralized store. Such a store will be simultaneously secure and private, with strong identity services, while also available anywhere.

Information and rights to that information will ideally follow an individual as she moves through various contexts in her daily life, enabled with the ability to provide trusted, verified identity within those contexts. A longitudinal record could be created, including consumer-generated application data, with the individual as the primary controller of access - all independent of a third party.

YouBase provides an individual-centric security structure that separates personal data from identity while allowing for secure and structured read and/or write access to trusted parties on a peer-to-peer data store. This structure provides several benefits, including:

  1. a way to securely input, access and share any kind of file or record
  2. a way to organize authorized access to information into a structured hierarchy
  3. improved anonymous information sharing that could be used as a public or shared private asset
  4. information sharing transactions can be to be tied to financial transactions
With these tools in place, we imagine a world where, rather than storing personal data, third parties could simply subscribe to data owned and controlled by the individual.
ePHI "controlled by the individual"? Yeah, Bushkin's "Medkaz" riff comes to mind.

Cutting to the chase of the YouBase paper:
Conclusion
In summary, using an HD Wallet to access a personal data store provides multiple benefits:

  • Data agnostic. Securely input, access and share any kind of file or record by providing keys and digital signatures.
  • Structured access. A way to organize authorized access to information into a structured hierarchy.
  • Authenticated data and proven identity without storing third party personal information.
  • Blockchain available, but not dependent. Information sharing transactions can be tied directly to a universal ledger as a public proof and/or as a financial transaction, but are not required to be. Wallets can be used solely as structured access to a data store, even though wallets are valid bitcoin addresses.
  • Encapsulation. Because each data element has a unique address, any one breach can be insulated from an attack on another.
  • Privacy. Without a high-level key, no one element of data can be tied to any other. With this level of data anonymity, more data can be donated by users for use in various forms of data commons.
  • A universal set of addresses. Using a public-private key hierarchy for data access provides for a universal address to read or write information based on an individual’s HD Wallet. A physician's office could send secure patient information to fulfill Meaningful Use requirements, for example.
  • Longitudinal tracking. All transactions are time-stamped, so all records can become a longitudinal record.
  • Security. Encryption of data by default.
  • Personal data as a service. Opens the door to have an API to share what you want with whom you want.
Sounds great. What's not to love? If you take all this gauzy "secure, seamless interop" stuff uncritically. The "HD Wallet" is unvarnished Bitcoin crypto.
Structured data
The core of the YouBase solution is a new kind of BIP32 hierarchical deterministic wallet or "HD Wallet" tree for the control of access to personal data stores. YouBase's wallet implementation follows the recommendations in BIP43 for extending BIP32, and can thus be thought of as BIP46, following the examples set in BIP44 and BIP45.

The HD Wallet contains a tree structure with extended keys such that each parent key can derive the children keys, children keys can derive the grandchildren keys, etc. An extended key consists of a private or public key and a chain code. Sharing an extended key gives (private or public) access to the entire branch. A useful application is that a user can provide an extended private key to a trusted source that can then write (deposit) information in that branch of the tree without having access to information in other branches.

Providing public/private key pairings in such a structure offers a number of benefits. First, specific branches can be used as data stores for specific types of information. Information secured in wallets can follow a pre-specified structure where different kinds of information are stored in different branches of the tree.

Secondly, along with that data structure, different rights to the tree have permissions structured such that different parties can have different read/write permissions to single nodes or to entire branches. Data can be partitioned into separate branches, allowing users to grant access on a granular level, down to the individual record, or even changes to a record. Specifically, a private key has read/write access to the data while a public key has read access only.

Third, HD Wallets are flexible in that they can create sequences of public keys without having access to the private keys, so that read-only or receive-only permission can be granted in less secure environments without risking access to the private keys. From the outside (with access to a public key), there is no indication that the key is part of any larger structure. It becomes a bitcoin address like any other...
Architecturally, I am reminded a bit here of my 80's lab days in Oak Ridge. Once we'd progressed to having a Netware LAN, we bought a LIMS package (Laboratory Information Management System) that was written in the "System J" language (basically a grab-bag mishmash of purloined elements of C, Fortran, Basic, Cobol, APL, Pascal, etc). It was ostensibly totally end-user modifiable and customizable. The database was not RDBMS, but rather a "hierarchical" node/stem/leaf "forms-based" construct.

We eventually ditched it and went full-bore Oracle RDBMS, first on a PC dumb-terminals client/server LAN running Unix (SCO Xenix), then, having scrapped that as well, on a DEC 3100 MicroVAX. Most of my bench-level apps work was xBase, with specialty library calls; all this other stuff just gave me whiplash. I moved on in 1991. Others toiled on with the endless LIMS project. I don't think it ever bore the fruit we'd all envisioned. Part of the problem was one that endures today. Lab managers and their staffs wanted to more effectively and efficiently manage lab throughput -- i.e., workflows. Corporate Suits wanted to surveill "productivity," in terms of money.

Sound familiar?
 
"YouBase is designed to provide a substrate on which any individual-centric service can be built."
Healthcare
There are a number of widely-known problems in health IT that an individual-centric data store could help solve.

Security Breaches in health care have become all-too-common because of the high value to identity thieves. A premium is paid on the black market for such records, estimated at $50 per record. In the US, in the first quarter of 2015 alone, nearly 90 million medical records have been compromised, including identity, clinical and financial information. At least part of the problem is misaligned incentives between third parties and patients. Providing a repository of data independent of a third party could provide a framework where personal data is provided on a subscription basis, rather than stored in multiple locations by multiple third parties.

  • Access. At the same time, a person's ability to access and manage personal information currently resting with third parties is difficult, recently leading to the #NoMUWithoutME and getmyhealthdata.org campaigns for personal health information access. Ideally, each person will have a private, universal and secure container of their own medical data that serves as a reference for health care stakeholders.
  • Interoperability. YouBase is data agnostic and could act as a single source for data, shared as needed and controlled by the patient, independent of data types. Data within the store could be translated between the various profiles. Any kind of data profile can be accepted and defined in the schema, so there's no need to pre-define the data structure before receiving the payload.
  • Research. Consumers can anonymously donate their validated data with minimal metadata or personal information. Consumers can have a personal container to directly connect their validated clinical and claims data, or provide this validated information to an external party.
  • Sending records from provider to patient. A set of universal addresses will allow for secure transmission of a patient record, simply by scanning a public address for which the health care provider has a private key.
  • Identification at point of care. YouBase can provide validated identity at the point of care through IDs, unique addresses and digital signatures, while maintaining privacy. Digital signatures will improve data quality.

    For example, a user could enter a lab and show that his identity matches with a traditional ID, or simply present his YouBase token that has been signed. The public key token is then verified as belonging to the user and documented in the system. The phlebotomist takes a blood sample, notes the date/time, and the sample is then permanently associated with the user's token/private key. The sample is processed using the lab's existing system. The results (data) are sent to the user's YouBase wallet and can only be opened/viewed by the token/secure-key.

    This could be applied to many health care transactions, creating validated identity and a universal set of addresses to which patient information could be signed. Using this kind of system will also improve data quality as each data entry will require a digital signature linked to the person who entered the information.
These are just a few examples. Our goal here is not to identify every use for the YouBase platform but to provide a starting point around which new ways of using trusted identity and privacy to manage health information can be imagined.
Be interesting to see whether this gets any traction in the healthcare space. Color me skeptical at this point. Securely, accurately, and efficiently moving around the hundreds to thousands of ePHI variables (many of them multi-encounter/longitudinal) connected to a given patient record differs materially from paying for CDs (or dope) with Bitcoins.

We'll see.

IN CLOSING, BACK TO PIETER CULLIS


Chapter 7:
THE GENIE IS OUT OF THE BOTTLE SO, WHERE ARE WE? In the previous six chapters, you have seen how the development and application of modern science over the last 400 years have led to an understanding of everything from planetary motion to the innermost workings of the cells in your body. You have learned about many of the bits and pieces that you’re made of, what they do, and how you can measure them, resulting in the “molecular you.” We have seen how the advent of the digital age allows us to store all this information electronically, and how analysis of the “digital you” embodied by this massive data cloud can identify biomarkers that provide an incredibly accurate picture of your state of health and disease. Remote-sensing devices can now analyze every breath you take and every beat of your heart and alert you well before you pass your best before, or rest in peace, date. Through social media, you will soon be able to share these intimate details with sympathetic listeners suffering from disorders just like yours, compare your digital selves to find the most effective therapies that should work for you, and locate where these are available. Taken together, these advances are driving massive changes in the practice of medicine as we know it today. But that’s only the beginning of the potential disruptions molecular medicine may cause...

The rapid advances in accurate diagnostics that can be anticipated in the near future, and their availability to you, will challenge the medical establishment’s role as the gatekeeper of medical advances, because knowledge and power will be passed to you, the consumer. For example, the current fifteen-year wait time for a new medical advance to reach the doctor’s office — to reach you — will not be tenable when you know with certainty what disorder you have, and have done your research as to which therapy is most appropriate to you and where it is available.

Certainly, personalized medicine will be creating havoc within the medical profession. The role of doctors in making diagnoses will be increasingly supplanted by computer analyses of the digital you. Accurate diagnoses combined with advanced imaging techniques and analyses of genomic and other data in the digital you will mean that safe and effective treatments will be readily identified. Thus the role of doctors will be in transition, as it has been for some time. Fifty years ago, doctors cared for people who were really unwell: 80 percent of their job was looking after the dying or seriously ill. Today, the treatment of chronic disease has become the norm. Care of type-2 diabetes, high blood pressure, arthritis, and cancer survivors takes up the majority of time. As these chronic disorders become increasingly controlled through a molecularly based, personalized approach, and as diagnosis and treatment are largely decided by analysis of the digital you, only complex and severe problems will need the doctor. So what will doctors be doing?


Two scenarios are possible. Those who do not have access to a doctor — or advanced health care — will find the playing field dramatically leveled. Relatively inexpensive omic data — potentially in the range of $ 100 for a complete analysis — and free online analyses available through the Internet will enable patients around the world to access state-of-the-art diagnostic resources. This information, combined with Internet searches and social media such as PatientsLikeMe, CureTogether, and other disease-specific websites, will also make it possible for you to discover what the most appropriate treatment is and where it is available... [op cit, Kindle Locations 1732-1810].
As I asked in the title:
Personalized Medicine" - will Health IT be up to the task?
Not a lot of time to be wasting, with tsunamis of Omics data approaching.


UPDATE

apropos of the increasing need for data exchange/"Interoperability" and the YouBase proffer, some interesting thoughts in Dr. Carter's latest post at EHR Science:
Future-Proofing Clinical Care Systems—Because, Well, Change is Constant
by JEROME CARTER on AUGUST 17, 2015


Everything changes. The workflows from last year may not exist next year. There will be new reporting requirements, new data elements, new forms, and new coding systems. Creating software that grows gracefully with the times takes serious architectural thinking from the outset...

It is no accident that current systems tend to be monolithic and hard to change without additional programming. As with most things in life, creating modular clinical systems is easier said than done. More importantly, modularity and configurability MUST be design goals from the very beginning, as they are not easily added after the fact...

Consider something as basic to EHR systems as the problem list. Problem list functionality could be provided in any number of ways. The simplest would be to treat the list as an array/collection of terms with start/stop dates. In a relational database, such a list would be stored in a single table. At the user interface, rendering of the list could be done using a simple grid, a multi-line text box, or be printed plainly in a window. Here we have the list in three modalities: in memory, in a data store, and presented on screen. In each instance, the problem list is simply treated as data—a series of values to be stored or displayed.

However, what if we decide to make the problem list (PL) a component? We know what the information role of the problem list is for users, but what is the functionality of a PL computationally? Here the question becomes what role the PL plays as a component of the EHR beyond its role as an information source for the user.

Now, consider this scenario. Chronic renal disease is added to the PL. Should there be a function in the PL component that automatically checks meds to suggest dosage adjustments? Should a PL component have a function that scans new labs to look for undiagnosed problems?

Treating a PL as a component that controls all diagnosis/problem functions requires a completely different software design than one that acts as a list and simply records/presents what the user has entered. Now we are considering functions that happen independently of any user interaction with the PL. Going a step further, let’s make the PL swappable (i.e., third-party vendors could sell a PL component that snapped into the EHR). Providing users the ability to swap out components would require yet another architectural adjustment...


The second version of modularity allows one to add a PL module to an EHR system in a way similar to adding a new app to a smartphone. This second version would allow updates to be installed after the EHR system is up and running. Imagine how owning an EHR would be when one could buy the PL from one company and the medication list from another. Don’t like the labs display? Swap it! Both versions of modularity are helpful, but the latter also prevents users from being tied to the innovativeness, or lack thereof, of any particular vendor...
'eh? "Modular EHR components as, in effect, plug & play "apps" that play nice together? Could such comprise the mature evolution of the still-tentative"API"? Read the entire post. Jerome Carter never disappoints.
__

CODA

Is our "interoperability" obsession a case of Tail-Wags-Dog?  See my post "Post-HIMSS15 Interoperababble Update: Margalit Gur-Arie hits one out of the park."
___

More to come...

Tuesday, August 11, 2015

Meaningful Use: the 30 billion dollar flush?


From FierceEMR:
Meaningful Use impact on physician EHR adoption 'weak'

The Meaningful Use program and its incentive payments lack "statistical significance" on physicians' adoption rates of electronic health records, according to a study in the Journal of the American Medical Informatics Association (JAMIA).

The researchers, from the University of Alabama at Birmingham's School of Public Health and elsewhere, assessed the impact of the Meaningful Use program on EHR uptake by examining adoption by nonfederal office-based physicians, excluding radiologists, anesthesiologists and pathologists. They used a diffusion model of new products to examine the shape of the diffusion curve to plot sales or share of potential market...
JAMIA ABSTRACT
Impact of the HITECH act on physicians’ adoption of electronic health records

Background and Objective The Health Information Technology for Economic and Clinical Health (HITECH) Act has distributed billions of dollars to physicians as incentives for adopting certified electronic health records (EHRs) through the meaningful use (MU) program ultimately aimed at improving healthcare outcomes. The authors examine the extent to which the MU program impacted the EHR adoption curve that existed prior to the Act.

Methods Bass and Gamma Shifted Gompertz (G/SG) diffusion models of the adoption of “Any” and “Basic” EHR systems in physicians’ offices using consistent data series covering 2001–2013 and 2006–2013, respectively, are estimated to determine if adoption was stimulated during either a PrePay (2009–2010) period of subsidy anticipation or a PostPay (2011–2013) period when payments were actually made.

Results
Adoption of Any EHR system may have increased by as much as 7 percentage points above the level predicted in the absence of the MU subsidies. This estimate, however, lacks statistical significance and becomes smaller or negative under alternative model specifications. No substantial effects are found for Basic systems. The models suggest that adoption was largely driven by “imitation” effects (q-coefficient) as physicians mimic their peers’ technology use or respond to mandates. Small and often insignificant “innovation” effects (p-coefficient) are found suggesting little enthusiasm by physicians who are leaders in technology adoption.

Conclusion The authors find weak evidence of the impact of the MU program on EHR uptake. This is consistent with reports that many current EHR systems reduce physician productivity, lack data sharing capabilities, and need to incorporate other key interoperability features (e.g., application program interfaces).
The paper is paywalled, so I can't get at all of it.

Yet.

From the source article:
The study's authors likened the Meaningful Use program to the "cash for clunkers" subsidies in the car industry, in that the Meaningful Use payments may have only contributed to "inevitable" adoption of EHRs. In fact, the program may have had negative unintended consequences, such as stifling technological innovation in favor of meeting "certified" technology.
Yeah. My irascible concern all along over at Clinic Monkey. Be interesting to see what upshot ensues in Congress -- if any.

MORE MU NEWS
Meaningful use of EHRs by doctors fell in 2014
By Joseph Conn  | August 12, 2015

Participation by office-based physicians in the electronic health-record incentive payment program waned significantly in 2014, the program's fourth year, as clinicians faced system upgrades and tougher requirements.

The number of physicians and other eligible professionals in ambulatory care who attested to having met the requirements of the multibillion-dollar federal program dropped by 12% last year compared with 2013 numbers, based on federal data for the type of EHR system these providers most commonly use.

Meanwhile, less than a third of the office-based providers using complete EHRs managed to step up to the program's more stringent Stage 2 requirements in 2014...
___

More to come...

Sunday, August 9, 2015

The health implications of U.S. gluttony


Saw this NY Times Op-Ed:
Incurable American Excess

A few years ago, Americans and Europeans were asked in a Pew Global Attitudes survey what was more important: “freedom to pursue life’s goals without state interference,” or “state guarantees that nobody is in need.” In the United States, 58 percent chose freedom and only 35 percent a state pledge to eradicate neediness. In Britain, the response was the opposite: 55 percent opted for state guarantees and just 38 percent for freedom. On the European Continent — in Germany, France and Spain — those considering state protection as more important than freedom from state interference rose to 62 percent.

This finding gets to the heart of trans-Atlantic differences. Americans, who dwell in a vast country, sparsely populated by European standards, are hardwired to the notion of individual self-reliance. Europeans, with two 20th-century experiences of cataclysmic societal fracture, are bound to the idea of social solidarity as prudent safeguard and guarantor of human decency. The French see the state as a noble idea and embodiment of citizens’ rights. Americans tend to see the state as a predator on those rights. The French ennoble the dutiful public servant. Americans ennoble the disruptive entrepreneur...


Individualism trumps all — and innovation, it is somehow believed, will save the country from individualism’s ravages. Paarlberg notes that: “Americans eat alone while at work, alone while commuting to work in the car, alone at the food court while shopping, alone at home while watching TV, and alone in front of the refrigerator both before and after normal mealtime.”

But if all that eating continues to generate obesity — as it will — Americans tend to put their faith in “improved bariatric surgeries, and new blockbuster diet drugs” that “will be challenges welcomed by America’s innovative and responsive private market institutions.” Rather than cut back, they prefer to consume more — whether fuel or food — and then find ways to offset excess...
Some of the reader comments were interesting:
IMO, there is an element that Mr. Cohen missed. We, as a nation was [sic] blessed with great natural resources, a brilliant Constitution, an individualistic approach to solving problems, two oceans isolating us from the brutal upheavals of the Twentieth Century and an abhorrence of socialism, which stood us well for a while; however, the human frailty of greed has gripped us because our institutions did not factor in a safety net. The result is an increasing cutthroat, inhumane system where people grasp at money because, in the US, it's the only means of surviving.

We stuff ourselves with food, worship the car to the point of polluting our air and choking both ourselves and our cities and consume emotionally for the illusion of well being. We are in denial because we naively believe American know-how will solve our problems with pills and quick fixes. This country will eventually collapse because of its excesses. We'll deregulate ourselves to death.

__

The problem is that the American individualism that you describe leaves Americans open to being herded, just like livestock. Over-consumption, in any form, represent enormously profitable businesses for one large corporation or another. These entrenched entities, in turn, exert outsize influence on the political process through the corrosive effects of campaign funding by corporations and their wealthy beneficiaries. Fundamentally the problem isn't American individualism, it's large corporations which have insidiously colonized the American people.
__

...."are hardwired to the notion of individual self-reliance."

I can think of no one less self-reliant than Americans who depend on processed food for nutrition, mechanical devices for the most minimal of efforts (leaf-blowers? come on!) and drugs and surgery, rather than self-discipline and physical effort, to relieve the consequences of their idleness. This extends to a mental laziness whereunder any initiative to alter behavior is dismissed as "Nanny State" meddling.

It's a curious combination of cynicism toward facts (climate change, or one's own ill-health) that might disturb the mind-set, and gullibility to reassurances from those with a clear interest in promoting unbridled consumption and squandering of resources. And no accident that push-button devices have replaced books, newspapers and thoughtful exchange of ideas as sources of information and decision-making.
The Op Ed cited this book:


So, I bought it and read it in one day. Very interesting. Examines two concurrent, statistically correlated adverse trends: overconsumption of both food and (predominantly dirty, extractive non-renewable) energy. For one thing, it brought to mind my May 1st post "Upstream, downstream; what happens to health when there IS no more stream?" and my post about the worsening U.S. drought.

Robert Paarlberg:
Preface
I am ordinarily suspicious of those who single out America for having fundamental flaws. In my own work, I freely criticize my country’s policy failings, but denigrating the nation itself is something I try to avoid. America’s reflexive critics too often have suspect motives or credentials. Some are Europeans, jealous of America’s wealth and influence, and resentful that their own historical moment has passed. Others are smug bicoastals who have never visited what they dismiss as “flyover country.” Still others are shallow utopians for whom all of reality is a disappointment.
My own motive for writing this book about America’s excess food and fuel consumption is more explanatory than judgmental, yet a sad judgment does emerge in the end. America’s inability to contain its overconsumption of food and fuel is not simply a policy failing; it is deeply rooted in the nation’s distinct material circumstances, its unique political institutions, and also its singular national culture. America’s overconsumption is overdetermined by national flaws that are in fact quite fundamental...

...In this book I stick to the...task of explaining why things are as they are...
The Origins of Excess 
Excessive food consumption has given the United States the highest obesity prevalence in the industrial world. At the same time, excessive consumption of fossil fuel makes America a global leader, by an equally wide margin, in per capita carbon dioxide (CO2) emissions. Other rich countries today are also prone to overconsume food and fuel, but why is America’s excess so extreme? Vaclav Smil, a distinguished Canadian geographer, has pointed out the “inescapable” parallels between these two dimensions of America’s excess, yet they have never been examined side by side (Smil 2011). In this book, I correct that omission.

Excess consumption on a society-wide basis first became possible during the second half of the twentieth century, thanks to a revolutionary decline in the cost of all consumable goods relative to income. Throughout most of human history, the use of food and fuel had been disciplined out of necessity because of high costs, so self-control did not have to be exercised. Then, during the second half of the twentieth century, personal incomes grew throughout the industrial world while the cost of securing both food and fuel dropped sharply, so overconsumption became a widespread social option. Our long-standing human struggle to obtain enough food and fuel was suddenly replaced by an unfamiliar new challenge: to avoid consuming too much.

In preindustrial societies today, the traditional struggle to secure enough food and fuel remains as challenging as before. In the African countryside today, one out of three adults is chronically undernourished. Purchasing enough food remains difficult because incomes are typically less than two dollars a day, and producing food is difficult because the prevailing agricultural techniques are primitive and unimproved. Fields are still cleared by hand, crops are still planted by hand, and weed control remains a time-consuming chore throughout the growing season. Then comes the labor of harvesting, winnowing, pounding, and drying the grain, followed by a daily trek on foot to fetch wood and water, and finally cooking the grain over a hand-built fire.

In traditional settings of this kind, the sustained overconsumption of either food or fuel is for most people a physical impossibility, and intentional waste is essentially unknown. Some grain is lost in the field to insect damage, and some is spoiled by rain or eaten by rodents in storage, but at the consumption stage almost nothing goes to waste. According to the World Bank, only 5 percent of food loss takes place at the consumption stage in sub-Saharan Africa, and the non-essential burning of scarce firewood is almost unheard of.

In today’s rich countries, by contrast, food and fuel are no longer scarce relative to income, so both are routinely wasted or consumed to excess. Fuel ceased being scarce when modern societies learned how to access the carbon and hydrocarbon energy supplies stored below ground in the form of coal, oil, and natural gas. These “fossil” supplies of fuel are the remains of plant and animal matter that incompletely decomposed over a period of 500 million years before humans. Once people began to access these fossil fuels and leverage them to power an industrial revolution, techniques for recovering still more fuel, and for growing more food, underwent spectacular improvement. Personal incomes increased across the board, so excess consumption of energy and food eventually became affordable for nearly all...

Paarlberg, Robert (2015-01-06). The United States of Excess: Gluttony and the Dark Side of American Exceptionalism (Kindle Locations 51-134). Oxford University Press. Kindle Edition.

With regard to our unsustainable energy overutilization, I observed on another blog in 2009,
We can choose to continue to drill, mine, cut down, and grind up the planet in pursuit of short-term business-as-usual, unevenly distributed consumerist comforts, but the day of tragically harsh mass reckoning draws ever closer. The lessons to be drawn from Jared Diamond's "Collapse" are compelling in this regard. There is no shortage whatsoever of constructive and remediative work to be done in support of a sustainable and broadly prosperous future for all of humanity. But, let's not kid ourselves that an unregulated "invisible hand free market" alone will suffice to insure its emergence. Recent economic history alone refutes that assertion.

To be sure, the U.S. comprises only ~5% of world population, and the responsibility of our federal government is constitutionally bound as a priority to address the "general welfare" of our own citizenry. However, we consume about 25% of the world's resources in the aggregate, and, given that our politicians never pass up an opportunity to extol the U.S. as "the greatest nation on earth," perhaps we might start acting like it in the area of sustainability leadership, for, in the end, humanity will survive or perish as a planet-wide species.
See also my 2008 post "0.0143"

More Robert Paarlberg:
Waste, in fact, is not the real issue. More serious are the physical harms we impose on ourselves by consuming too much. Excessive consumption of fossil fuel is now destabilizing the Earth’s climate. A National Climate Assessment in the United States in 2014 found that a number of events linked to higher greenhouse gas concentrations were already imposing costs such as increased heat and drought in the Southwest, more punishing rains and coastal flooding in the East, and shrinking glaciers in Alaska (USGC Research Program 2014). In 2014, the Intergovernmental Panel on Climate Change (IPCC) warned that a continued increase in atmospheric concentrations of greenhouse gases such as CO2 would lead to “severe and widespread impacts on unique and threatened systems, substantial species extinction, [and] large risks to global and regional food security….” A tipping point might eventually be reached, resulting in “abrupt and irreversible change” (IPCC 2014).

In parallel fashion, the excessive consumption of food has destabilized energy balances within the human body, bringing on a “metabolic syndrome” consisting of increased blood pressure, high blood sugar levels, excess body fat around the waist, and abnormal cholesterol levels. These factors increase personal risks of heart disease, stroke, and diabetes (Mayo Clinic 2013). America’s Centers for Disease Control and Prevention (CDC) report that when an individual becomes obese (clinically defined as a body mass index greater than 30) risks also increase for cancers, liver and gallbladder disease, sleep apnea and respiratory problems, osteoarthritis, and gynecological problems including infertility for women (CDC 2012a).

Because food and fuel no longer ration themselves, unprecedented self-disciplines must now be constructed, at both the social and individual level. This is extremely difficult with both food and fuel, yet for completely different reasons. For climate change, disciplines are difficult to enforce because the payoffs will not be noticed immediately by those making the consumption sacrifice. Climate change is driven by an accumulated stock of greenhouse gases in the atmosphere, not by small changes in annual emissions flows. Even if annual flows are cut sharply, the accumulated stock changes very little at first, so current trends in temperature increase can remain essentially unaltered for decades (IPCC 2014, p. 10). Also, when the payoffs do finally come, they will take the form of bad things that did not happen, which are always hard to notice, measure, and document. In addition, the payoff will only come if all of the largest industrial countries agree to share in the sacrifice, a global cooperation problem that has yet to be solved.

For food consumption, constructing self-imposed disciplines will be hard for entirely different reasons. At an individual level, the health benefits derived from more disciplined eating can be noticed and measured almost immediately, and they can be secured without global cooperation. By reducing calorie intake by 500– 1,000 calories per day while maintaining a constant level of physical activity, an individual will immediately begin to lose about 1 to 2 pounds of body weight every week, and even a modest weight loss of 5– 10 percent of total body weight usually brings measurable improvements in blood pressure, blood cholesterol, and blood sugars (CDC 2011). Individuals can experience these gains even if their friends and neighbors are continuing to overconsume. [op cit, Kindle Locations 157-184]
190 pages of elegantly written prose buttressed by mountains of data from around the world. The end note citations and index alone run another 138 pages.

Paarlberg posits two remedial action categories:
  • Mitigation, vs
  • Adaptation
On the energy side, mitigation goes to proactive policies and measures such as limits on greenhouse gas emissions, along with measures to incentivize non-CO2 renewables (interestingly, no discussion given to nuclear options; only a few references to nuke plant shutdowns appear in the book). On the food overconsumption side, mitigation goes largely to things like tax/regulatory policies and "voluntary" initiatives that discourage junk food and beverage consumption, along with exercise (e.g., think Michelle Obama).

As to "adaptation," well, we can build more levees, harden our shelters, and ramp up emergency response infrastructure capacity to combat the effects of anthropomorphic-driven climate change, and we can expand clinical capacity to deal with the increasing prevalence of lifestyle-correlated maladies wrought in significant measure by excess consumption of food (concomitant with decreased levels of routine, sustained individual exercise regimens).

Paarlberg unhappily concludes that, in the U.S., "adaptive" tactics will likely hold sway, particularly on the energy side of things, owing to our political system and cultural evolution constraints, and given the skewed distributions (and relative immediacy) of risks and benefits. On the health"upstream" side, "mitigation" goes more (albeit not exclusively) toward "prevention," whereas "adaptation" goes to post-dx "treatment."

How much of our currently deployed Health IT can even contribute materially to the public health "big data" we'll need to have to know where we stand across time?

Asked and answered.

I find this an important book. Highly recommended.
Conclusion
America’s inability to reduce excessive food and fuel consumption at home will therefore generate divergent outcomes for the rest of the world. In the difficult area of climate change, America’s policy drift toward self-protective adaptation will undercut its already weak efforts to reduce CO2 emissions, thus significantly increasing climate risks for others who lack self-protection options. In the area of obesity, however, lax mitigation efforts in America will not diminish mitigation options for governments abroad, and the new treatments that American researchers are likely to develop will be available for export, ensuring an international benefit.

This may seem to be a Janus-faced outcome, but America has in fact failed equally and in the same way on both fronts. The impact on others is divergent only because America’s performance remains critical to the global outcome for climate change, but not for obesity. The manner in which America has been falling short on both fronts is not only identical, but identically unattractive. In each case, America’s approach is a form of sauve qui peut. In response to climate change, America pivots toward adaptation to protect itself, and itself alone. With obesity, America’s embrace of personal rather than government responsibility works well enough for the nation’s more fortunate citizens, those better educated to avoid the condition and better able to afford medical treatments. For Americans with less education and fewer resources, particularly disadvantaged minorities, personal responsibility without stronger public policy action will remain inadequate. Conclusions such as these, which point to flaws in national character, are painful to reach but impossible to avoid. [ibid, Kindle Locations 3082-3095]
__

JUNK FOOD GLUTTONY UPDATE

From The Incidental Economist.


Gross.

OFF-TOPIC ERRATUM

Your Daily Donald™
___

More to come...

Thursday, August 6, 2015

Are EHRs obsolete?

Hardly, but,
"The majority of EHR systems in use today were designed more than five years ago, and the largest systems used by hospitals systems date back 15 years or earlier. They were designed to fit the constraints that existed at the time."
- Jerome Carter, MD, EHR Science, "Clinical Care Systems: The Next Generation"

I've been working with computer systems for nearly 30 years -- not counting undergrad school at UTK, where I learned to write SAS and SPSS code and associated mainframe JCL (Job Control Language). From January 1986 thru mid-1991, using 3GL and 4GL compilers and RDBMS platforms (Oracle, xBase), I developed laboratory bench "apps" for computing environmental radiation exposure/dose/contamination and concomitant SPC code (pdf), and business office reporting programs in Oak Ridge.

Ten years ago I left the bank where I'd been a credit risk analyst, modeler, and writer (pdf) for 5 years, and returned to HealthInsight to participate in the federal DOQ-IT program, which was funded by CMS to stimulate wider adoption of "EMRs" (Electronic Medical Records). "EMRs" gradually came to be alternatively/synonymously called "EHRs" (Electronic Health Records). Eventually, an inferential distinction came to pass. Again, Dr. Carter:
The terminology shift from computer-based patient record to electronic health record occurred in 2003 when the report, Key Capabilities of an Electronic Health Record, was released.   As part of that terminology change, EHR systems were defined to be different from EMR systems, principally based on expected interoperability features. Here is how the ONC described EHR systems in 2011.
Electronic health records (EHRs) do all those things—and more. EHRs focus on the total health of the patient—going beyond standard clinical data collected in the provider’s office and inclusive of a broader view on a patient’s care. EHRs are designed to reach out beyond the health organization that originally collects and compiles the information. They are built to share information with other health care providers, such as laboratories and specialists, so they contain information from all the clinicians involved in the patient’s care. The National Alliance for Health Information Technology stated that EHR data “can be created, managed, and consulted by authorized clinicians and staff across more than one healthcare organization.”
Like the computer-based patient record before it, the EHR as described by the ONC still does not exist – interoperability as envisioned by the ONC has not yet made its debut.
Yeah. We remain largely mired in "Interoperababble" and fragmented "shards of health care." (To be fair, the bulk of the chronic -- and perhaps worsening -- fragmentation goes to dysfunctional economic imperatives and policy inadequacy, not technology.)

 More Jerome Carter:
In the early 2000s, LAN-based client/server was big and broadband Internet access, a luxury. The cloud and mobile devices with 64-bit processors, touch-based interfaces, voice-recognition, and an array of sensors were unknown. Workflow technology suitable for use in clinical systems did not exist a decade and a half ago; now many good systems are available.

Unfortunately, much of the current thinking about clinical care systems fails to acknowledge that many past constraints have been removed. Workflow issues and workarounds are widely discussed, and AHRQ and NIST have provided detailed reports that critically assess workflow issues. Yet, for some reason, workflow technology is rarely mentioned. We have new tools, good research on clinical work needs, and a new computing environment. It is time to try a new approach; it is time to start from scratch...
In 2010 I returned yet again to HealthInsight (I would introduce myself to outsiders as "the Bad Penny of HealthInsight") to work in the Meaningful Use initiative via their Nevada/Utah REC -- the work that launched this blog on May 10th, 2010.

So, where are we today, and where are we headed? The Meaningful Use effort is essentially over (the looming, much-unloved "Stage 3" notwithstanding), the overwhelming bulk of the incentive money having been distributed. Meaningful Use has been quite good to my Clinic Monkey EHR, I have to say.

More Jerome:
Looking back over the last 50 years, the effects of computer generational changes quickly rippled throughout society.   Personal computers moved computing power from businesses to individuals, and the market for word processors and other productivity software exploded. LANs allowed small businesses to access software previously only affordable to larger enterprises.   The Internet has reshaped entire domains. Amazon is in; Borders is out. Netflix is in; Blockbuster is out. The last three cars bought by my family were located online and picked up at CarMax.

Workflow technology, powerful mobile devices, and cloud data storage represent the newest generation of information technology. Provisioning cloud servers is significantly easier than just two years ago.   Databases have changed as well – there are now ACID-compliant NoSQL systems.

Computing technology has moved forward much faster than I expected...
"ACID-compliant NoSQL"? Lordy.

ACID
ACID is a set of properties that apply specifically to database transactions, defined as follows:

  • Atomicity - Everything in a transaction must happen successfully or none of the changes are committed. This avoids a transaction that changes multiple pieces of data from failing halfway and only making a few changes.
  • Consistency - The data will only be committed if it passes all the rules in place in the database (ie: data types, triggers, constraints, etc).
  • Isolation - Transactions won't affect other transactions by changing data that another operation is counting on; and other users won't see partial results of a transaction in progress (depending on isolation mode).
  • Durability - Once data is committed, it is durably stored and safe against errors, crashes or any other (software) malfunctions within the database.
SQL / Relational DB
ACID is commonly provided by most classic relational databases like MySQL, Microsoft SQL Server, Oracle and others. These databases are known for storing data in spreadsheet-like tables that have their columns and data types strictly defined. The tables can have relationships between each other and the data is queried with SQL (Structured Query Language), which is a standardized language for working with databases.

NoSQL
With the massive amounts of data being created by modern companies, alternative databases have been developed to deal with the scaling and performance issues of existing systems as well as be a better fit for the kind of data created. NoSQL databases are what these alternatives are called because many do not support SQL as a way to query the data...
From "What is the relation between SQL, NoSQL, the CAP theorem and ACID?"

Maybe I'm just an out-to-pasture Old Coot by now, 5 months away from being able to call myself a "70 year old washed-up ex rocker," but all I see here is the continuing necessity for code logic exactitude (irrespective of the development languages) and data matching, collation, merging, and synthesizing, all this geek-speak ACID-dropping aside.

More on ACID and NoSQL:
DataStax CEO: Let's clear the air about NoSQL and ACID
Many still believe NoSQL databases can't play at same level as relational forbearers. DataStax CEO Billy Bosworth puts the notion to rest

Misconception No. 1: You can't build an online application without ACID compliance
 

This misconception is flat out wrong and largely stems from built-in biases that we RDBMS folks have developed over the past two decades. Fortunately, you can easily find hundreds of companies such as eBay, Instagram, and Netflix building mission-critical online applications without full ACID compliance.

Misconception No. 2: ACID is an all-or-nothing proposition
 

Many people forget that ACID is an acronym representing four distinct characteristics: atomicity, consistency, isolation, and durability. In today's world of online applications, developers and architects make trade-offs to serve the greatest need.

Modern NoSQL databases offer various pieces of ACID that serve the needs of a given application just fine. Postrelational technologies often sacrifice consistency for performance reasons, while following (at least partially) the "AID" aspects of ACID. That's what I mean when I say it's not an all-or-nothing proposition. Parts of ACID may still remain relevant for your application, so you optimize for those accordingly.

Misconception No. 3: Eventual consistency violates the "C" in "ACID"
 

A few years ago, I wrote a blog post to address this misconception more thoroughly, but the gist is that for many DBAs, the word "consistency" has two very different meanings. "Consistency" in ACID refers to the enforcement of constraints or rules for a given entry in a database. When we talk about eventual consistency in a database such as Cassandra, we mean something entirely different -- namely, the temporal accuracy of the data itself.

In a distributed system, the same piece of data is usually replicated to multiple machines. When you update that piece of information on one of the machines, it may take some time (usually milliseconds) to reach every machine that holds the replicated data. This creates the possibility that you might get information that hasn't yet updated on the replica. In the old relational world, this conundrum comes very close to what we call a "dirty read."

This approach can present its own set of challenges at times, but the point is that eventual consistency is a different issue than the consistency definition you find in ACID. In order for developers to appropriately manage this new dynamic, it's important that they not confuse the two definitions.

Misconception No. 4: Databases and applications have a 1:1 relationship, so it's either/or between relational and NoSQL technologies
 

Years ago when we wrote applications at much smaller scale, life was easy: We picked a database, wrote our application, and were done. In fact, a single database system such as an Oracle instance would often house multiple schemas that represented different applications.

Today's applications are much more sophisticated. The idea of running a single database technology for a datastore is passé. A few years ago, Martin Fowler highlighted a trend called "polyglot persistence" that is now the normative architecture for modern applications. Virtually every customer I talk to houses a services layer between multiple database technologies and the app they power. This trend has established itself firmly in the real world. Polyglot persistence allows us to use the right technology for the right workload inside an application, which can pay huge dividends and enable functionalities not possible in a 1:1 schema.

Misconception No. 5: NoSQL databases are for "Web scale" applications only; everything else uses ACID-compliant technology
 

Some people believe that only a niche subset of applications require scalable, distributed databases. If you stop and think about it, how many developers today build online applications that don't keep "Web scale" in mind? It's like saying, "Only a small number of cars require the speeds necessary for highway travel."

That may have been true when only a few highways existed, but now they are part of everyday travel. The same is true for Web-scale applications. Given the always-connected nature of endpoints -- whether they are users, devices, or sensors -- what other kind of online application would you write? When are performance and availability not a high priority?

Why it matters
 

Over a decade has passed since Eric Brewer presented his now famous Brewer's Conjecture, which laypeople ultimately learned as the CAP theorem. It got us all thinking that the ability to scale out -- represented by "Partition tolerance" (the "P" in "CAP") -- might be important enough to abandon something as sacrosanct as data consistency within an application. He was right. Today, two attributes reign supreme for online applications: availability and performance. Without both, it's nearly impossible to satisfy the insatiable flow of data and unyielding demands from users...
Yeah. Interesting.

Meanwhile, back down out of the stratosphere, what do individual clinicians continue to mundanely see on a daily basis?


This is a NextGen HPI screen (History of Present Illness) for rheumatology. It is nothing more than a RDBMS data input/update/recall template, one comprising about 120 variables (depending on how you count them). One of the numerous data input screens clinicians and their support staffs must quickly traverse every day -- Admin/Insurance/Demographics, Active Problems, Active Meds (and Rx ordering), PMH, CC, HPI, ROS, Progress Note, etc -- all of the myriad elements comprising the SOAPe. See my July 2012 post "Analytics - SAS, R, SQL, EHR database schema. An old school data miner's ramble involving the intersections of workflow, audit logging, and CER, etc."

As I've noted before, a typical full-featured EMR/EHR has to house about 4,000 variables, typically distributed among perhaps hundreds of RDBMS tables in the application's schema. Much of the workflow travail that so irritates clinicians has little to do with Health IT per se, but rather is principally a function of the prevailing "productivity treadmill" economic imperatives.

One reason we remain stymied with respect to (the misnomer) "interoperability" is that we have failed to require a "Data Dictionary Standard."

No biggie? Just drop some ACID, take 2 API's, and call me in the morning? Are the MU-compliant incumbent EHR's effectively obsolete? Or verging on it?

The pace of Health IT R&D ferment is difficult to keep a good grasp on. Much of it remains "silo'ed," proprietary," and inscrutable to the harried end-users. More bamboozlement inevitably awaits.

"Will Silicon Valley's digerati "solve" healthcare?"

I will continue to count on people like Dr. Carter at EHR Science for Health IT clarity.

QUOTE OF THE DAY
Health care nowadays is like the ticker tape of a hyperactive stock market gone mad. Everything is huge, disruptive and transformative for a few days until the next seismic shock rolls in. Since nothing means anything in particular, everything means exactly what each expert wishes it would mean.

- Margalit Gur-Arie
ERRATUM

apropos of HIPAA, this is worrisome.

"...we will access, disclose and preserve personal data, including your content (such as the content of your emails, other private communications or files in private folders), when we have a good faith belief that doing so is necessary."
Seriously?
__

Off-topic. As I prepare for tonight's GOP "debate" and drinking game, Your Daily Donald™

CODA

Talk sbout "futurists" -


My latest New Yorker just arrived.


___

More to come...

Monday, August 3, 2015

Healthcare: I'm in a New York State of Mind

Thinking a lot about New York of late, the place where I was born (Rockeville Centre, Long Island) and where most of my kin have always lived (Queens, western Long Island, Elmont, Floral Park area).
My late Mother's younger sister Edna died last year at age 90. She left her house in Elmont, where she'd lived since I was a kid, equally to my sister and I and one of her long-time home caregivers. We'd had no idea. My sister is acting as Executor. She got notice several weeks ago of a lien placed against the property (we have it on the market, and there is a buyer pending) by NY Medicaid for about $89,000 in "claw-back" monies for Edna's recent end-of-life hospital care. Interesting. The aged little house is so out-of-code it probably needs to be bulldozed. The property is really only worth what the lot will bring. When the state and the lawyer are finished with us, there won't be much net to divide.
I actually grew up in northern New Jersey -- Morristown, East Hanover, Somerville, each about 30 miles or so out of Manhattan. My late Dad worked his entire civilian career for Bell Labs, first at Murray Hill, then Whippany. Semiconducters R&D. Geeky, pocket protector kind of guy. I come by it honest.

In November 2013 I covered the NYeC 2013 Digital Health Conference (see here as well). New York is in fact doing great things in the healthcare space.

NYC's most visible (and audible) resident has been making all manner of waves of late. As reported by Politico,
Billionaire businessman Donald Trump on Wednesday offered a glimpse into his presidential platform on healthcare, saying he would replace ObamaCare with “something terrific.”

“It’s gotta go,” Trump said of ObamaCare in an interview Wednesday with CNN. “Repeal and replace with something terrific."
I've started a new initiative on Twitter called "Your Daily Donald™"



Mostly quickie Photoshop jabs at this incoherent, narcissistic, garrulous blowhard.

Dude is "terrific." Just ask him.

Whatever. The first GOP "debate" on Thursday will be, well, Pass The Popcorn.

UPDATE: from PolitiFact, "Is Donald Trump still 'for single-payer' health care?"
__

Back to reality. Having just finished Steve Brill's fine book "America's Bitter Pill" (see my prior post), I looked about online to see what, if anything, was new with David Goldhill, cited in Brill's book (and whom I'd cited on another blog back in 2009).

Paydirt.


An edited compilation. Truly a bargain on Amazon at 99 cents, Kindle edition. Seeing the private-markets-are-a-panacea "American Enterprise Institute," "The Heritage Foundation," and "The Manhattan Institute" cited required a bit of "check-your-dubiety-at-the-door." Proved worth the effort.
Foreword

Denis A. Cortese, MD 
Robert K. Smoldt, MBA 

A patient facing a serious or life-threatening illness needs an accurate diagnosis and effective treatment. The same is true for the U.S. health care system. America’s health care costs per person and as a percentage of its economy are the highest in the world, threatening the long-term solvency of U.S. states and the federal government. Despite such outsize spending, patient outcomes, safety, and access to appropriate care are too often disparate and inconsistent. The good news: for a variety of reasons, many of the system’s key players appear ready to make fundamental changes that will move the U.S. to higher-value health care.

...When calculating value, cost is perhaps the factor most likely to be misdiagnosed. Some observers believe that simply lowering the amount paid for various services (per physician visit, per lab test, per imaging test, per surgery, etc.) will solve America’s health care cost problem. Yet decades of experience reveal that low-deductible health insurance and price controls do not reduce total spending. If anything, the opposite is true...

New York’s Next Health Care Revolution: How Public and Private Employers Can Empower Patients and Consumers offers a bold new approach by recognizing that reforms need not only happen at the national level; local changes, spurred by government and the private sector, can also lead to significant improvements. The essays herein are equally infused with a justified dose of optimism: reform efforts, thanks to a confluence of factors, including the Affordable Care Act and a growing number of effective, private-sector health care experiments, are beginning to spur the changes necessary to make the delivery of high-value health care the cornerstone of American medicine...

Rethinking the state’s role in competition—from regulating insurance to encouraging nimble new competitors who can re-bundle health care services (via telemedicine and direct contracting, for example)—can lower costs and launch virtuous cycles of value-focused innovation.

The key to bringing more value to patients is to introduce incentives that reward the provision of high-value care. Patient-centered reforms— including greater transparency, private exchanges, and value-based payment and benefit designs—will likely unleash a wave of positive change that grows in force over time. Of

As Joseph Antos explains in Chapter 2: “Payment reform can discourage the fragmentation and overutilization that has defined fee-for-service contracts to date, while encouraging innovation and competition in the delivery of care.” 


Indeed, when we pay for value, we’re more likely to get it. By channeling competition at the level of the patient-consumer, we can ensure that the providers who deliver the best value to patients will be rewarded, creating demand for yet more innovation.
 

(2015-05-20). NEW YORK'S NEXT HEALTH CARE REVOLUTION: How Employers Can Empower Patients and Consumers (pp xi - 1). Manhattan Institute. Kindle Edition. 
They had me at "Fragmentation."
A patient facing a serious or life-threatening illness needs an accurate diagnosis and effective treatment.
Well, in my case, I think I now have the former and will soon begin the latter. But, getting there has neither been simple nor easy. I know: 'welcome to the club.'

We'll triangulate this book with Brill's and Elhuage's and a number of relevant others I've already cited as this post progresses.
Fragmentation 
Highly competitive on nearly every other front, New York, like most other states, is astonishingly accepting of huge pricing disparities in health care. Consider the following 2012 tale of two Manhattan hospitals: at the public Metropolitan Hospital, the bill for a patient discharged with a heart attack (diagnosis-related group code 280) was $22,000; at the nearby private Lenox Hill Hospital, it totaled $112,000.14 New York is not alone. In Philadelphia, the price of echocardiograms (ultrasound images of the heart) ranged from $700 to $12,000, according to the New York Times...

New York’s unusually high costs are explained, in part, by the fact that its medical landscape is marked by fragmentation and little vertical integration, which means few incentives for providers to control expenses. Certain other states, by contrast, have large medical groups and integrated systems, such as Kaiser Permanente. Located in California, Colorado, and Georgia, among others, Kaiser owns all the hospitals and employs all the doctors in its network, thereby maintaining tighter control over costs and quality... [ibid, pg. 24].
Interestingly, search through Steve Brill's book and the variants of the word "fragment" are nowhere to be found. But, then, "America's Bitter Pill" is mostly a history of the byzantine politics of the enactment of the PPACA and the subsequent Healthcare.gov launch debacle.

Searching on the loosely synonymous "coordinate" yields only a few weak results such as
Notably, the June 16 speech contained none of Obama’s campaign trail attacks on the drug companies or insurers. Instead, the president promised savings that could come through better electronic medical records, more efficient use of prescription drugs, and more coordinated care overall...

Brill, Steven (2015-01-05). America's Bitter Pill: Money, Politics, Backroom Deals, and the Fight to Fix Our Broken Healthcare System (Kindle Locations 2052-2054). Random House Publishing Group. Kindle Edition.
With respect to Health IT, "New York's Next Health Care Revolution" gives us the predictable stuff we've all been hearing for years:
Interoperability would break down health systems’ “walled gardens” that have trapped information on quality and outcomes within individual systems. Interoperability would incentivize competition among insurers, too, by easily allowing consumers to take their health care information with them when switching plans. (Given robust competition on state health insurance exchanges to become the benchmark plan for federal premium subsidies, many consumers will likely switch plans annually to keep premiums down.)

Interoperable health records would reduce wasteful duplication of tests and needless paperwork, improving continuity of care. Interoperable electronic health records (EHRs) would spur medical research by allowing data-analytics platforms to scan millions of records to identify disease patterns, predict and prevent adverse events, and advance the most effective treatments for specialized groups of patients. Indeed, as genomic data and targeted therapies for complex chronic ailments become routine, interoperable EHRs represent the future foundation of precision medicine. [op cit, pg 74].
Yeah. The "Interoperability Is Good" riff.


Progress remains slow and halting. "Interoperababble" remains the norm, given the continuing competing incumbents' private market margin imperatives of opacity.

Maybe it'll be API's to the rescue. Eventually.

BTW, interesting that "Oscar Health" is cited in both books. Fascinating young company.

Brill on obstacles to the way forward, in a series of self-posed questions and answers:
STUCK IN THE JALOPY 

THIS IS THE PART WHERE I AM SUPPOSED TO TELL YOU WHAT I MAKE of all this— what the Obamacare saga really means, what it portends, and what we might do about it.

First, the easy stuff that I was thinking about as the enrollment returns came in on March 31, 2014. 

Do I wish that the National War Labor Board had ruled in 1943 that health insurance benefits did, in fact, count as wages and, therefore, that adding them would not be allowed under the wartime wage control regulations? 

Sure. Along with the follow-on decision by the IRS that insurance benefits could be tax free, that was the fork in the road that set the United States off in the wrong direction— putting employers on track to be the primary providers of health insurance. That is a different path from that taken by every other developed country, all of which produce the same or better healthcare results than we do at a far lower cost. Without employers offering insurance to workers, the pressure on politicians to provide a public program would have been unstoppable. 

America’s dysfunctional healthcare house, with the bad plumbing and electricity, leaky roof, broken windows, and rotting floors, would never have been built and become so entrenched in its special interest foundations that it could not be torn down. We would have never been stuck with the broken-down jalopy that we could only repair piecemeal. Pick your favorite metaphor for the hurdles faced by reformers for the past seven decades... [Brill, op cit, Locations 6546-6559].
It's a long, thoughtful chapter. Mr. Brill (himself a New Yorker, btw) basically argues for heavily regulated private market competition under a vertical and horizontal "public utility" model (very similar to a number of our EU counterparts). Think a bunch of  Kaisers all doing battle on patient-centered quality of care.
The first regulation would require that any market have at least two of these big, fully integrated provider– insurance company players. There could be no monopolies, only oligopolies, as antitrust lawyers would call them. The larger markets, such as New York, Los Angeles, and Chicago, might have to have four or five or even more players to make the competition real and to make sure, with accompanying regulatory requirements, that their footprints were big enough and their marketing plans robust enough to serve patients throughout their regions, not just in the wealthier areas. [ibid, Locations 7033-7037].
I've thoroughly enjoyed -- and highly recommend -- both books. Would love to get JD Kleinke's take on all of this.

Also, in light of some of Steve Brill's recommendations for physician-led organizations as part of effective reform, another book I've cited comes to mind. See my post "Physician, Heal Thy System."


apropos of this theme, a number of other works come to mind. e.g., Jonathan Bush's "Where Does It Hurt," Vik Khanna's "Your Personal Affordable Care  Act," and Jed Graham's "Obamacare is a Great Mess," to cite just a few I've reviewed.

I guess the thing that bothers me most about "New York's Next Health Care Revolution" is -- aside from its unwavering faith in private markets -- its advocacy of continuing employers as the principal intermediaries for the provision of health insurance for the bilk of the civilian population (including via the vehicle of "private exchanges"). Elhauge has long argued cogently for the de-coupling of health insurance from employment.
As I see it, the strength of the market paradigm are the standard ones: if consumers are knowledgeable, have similar resources, and have incentives to trade off the benefits and costs of each product, then market competition promotes productive efficiency, accommodates varying consumer preferences, and achieves allocative efficiency. The problem of unequal resources is largely external to the market paradigm and potentially remediable through vouchers. But the more fundamental problem of the healthcare market flows from an inherent division between knowledge and incentives. Unlike other markets no decisionmaker exists who has both the knowledge and the incentives to decide when the costs of supplying a particular good or service exceed its social value. Patients lack the knowledge and, even the fact that others (such as insurers or employers) cover much of the social costs, also generally lack the necessary incentives. Physicians and other healthcare providers are knowledgeable about medicine but not about social benefits and costs. Moreover, under current American market systems they either have incentives to provide too much care (if paid on a fee-for-service basis) or incentives to provide too little care (if paid on a capitation basis). Insurance plans generally lack the information to make case-by-case cost than if it decisions and have incentives to provide two little care, or to select for low-risk enrollees unlikely to need much care, because the insurers pay the cost of health care but do not enjoy its benefits…
That was 1994, in "Allocating Health Care Morally," which I cited in 2009 in my post "The U.S. health care policy morass." Elhauge goes on to explicitly advocate taking employers out of the health insurance business.
To ground my analysis, let me assert up front a concrete proposal, one toward which I believe the national health care systems of the world are (from different directions) slowly converging. The analysis of the moral paradigm offered here supports, when coupled with the strengths and weaknesses of the other paradigms, a health care system having the following elements.
  1. A politically set annual health care budget with an associated tax not linked to employment [emphasis mine].
  2. Free access for all individuals to a care-allocating plan.
  3. Individual choice about which plan they wish to join for some significant period (I suggest three years).
  4. Competition among care-allocating plans that each receive a share of the government budget based on the number of individuals they enroll, adjusted for each person's health risk, and that cannot retain profits from their budget (other than a possible bonus linked to total number of enrollees) but must instead spend it on those enrollees. Plans must accept all who wish to enroll... [pg 1453]
A generation later, we still retain the core notion of employer-based health insurance, notwithstanding that average length of employment tenure continues to decline, with all of the administrative churn it inexorably brings.

One last Elhauge swimming-against-the-tide observation:
An egalitarian distribution of health care is less likely to undermine productive incentives than an egalitarian distribution of cash, food, clothing, or shelter. People do not want to be sick, and (leaving aside hypochondriacs) have no desire for health care unless they are sick. There is thus no incentive to stay sick in order to get health care. In fact, getting well eliminates the need. Nor does the distribution of health care greatly reduce the incentive to work since working is still necessary to buy the basics in life. Moreover, the concern about work disincentives is weaker for sick individuals because illness often disables one from working anyway... [ibid, pg 1488].
__

DAVE CHASE ON LINKEDIN
Are We Seeing the First Stages of a Velvet Medical Revolution?

It is only after a revolution happens that one can clearly look back and see what triggered the revolution.Generational discontinuities and external factors such as technology shifts can create the conditions for a revolution where it may not have been possible before. Consequently, I think we may be seeing a revolution’s first phase happen before our eyes.   

I’m convinced that the only way there will be a true revolution in healthcare is if there is a partnership between individuals (aka patients/consumers/people) and clinicians. One without the other won’t get the job done. However, I feel doctors will play a catalyzing role. As I’ve been a Johnny Appleseed of sorts chronicling the far-reaching and transformational work of doc-entrepreneurs, it feeds my optimism that it’s possible to overcome the Preservatives who have 3 trillion reasons to protect the status quo...
A good read.

SHARDS UPDATE

August 4th. My urology clinic is maddeningly non-communicative. Not even an email address link on their website. A staffer called me today in response to repeated messages I left. Now I'm told that they cannot do my Calypso beacons implant px until August 18th, and I have to go to their Oakland facility for the procedure. This will effectively put the onset of my IMRT tx off until probably September. I posted a secure message on my RadOnc clinic's new (and clunky) portal.
Dear Xxxxxx Xxxxxxx Oncology & Hematology,

I am experiencing a lot of delay with XxxXxx Urology regarding the Calypso beacons implant px you ordered. They are difficult to communicate with, and slow to act. Today a staffer called me back to say they will now not be able to do this procedure until August 18th, which will set me back likely until just about September to begin my IMRT tx. 


Given the indeterminacy of the aggressiveness of my prostate cancer, should I be worried over this? 

It seems problematic now; trying to find another urologist to do this may not speed things up. 

Any advice? 

Sincerely,
Robert Gladd
I continue to be fragged.
__

PS: YOUR DAILY DONALD™


Seriously, America? Below, transcript of a recent live Trump response to a questions about the contentious proposed Iranian nuclear agreement.

"Look, having nuclear—my uncle was a great professor and scientist and engineer, Dr. John Trump at MIT; good genes, very good genes, okay, very smart, the Wharton School of Finance, very good, very smart—you know, if you’re a conservative Republican, if I were a liberal, if, like, okay, if I ran as a liberal Democrat, they would say I'm one of the smartest people anywhere in the world—it’s true!—but when you're a conservative Republican they try—oh, do they do a number—that’s why I always start off: Went to Wharton, was a good student, went there, went there, did this, built a fortune—you know I have to give my like credentials all the time, because we’re a little disadvantaged—but you look at the nuclear deal, the thing that really bothers me—it would have been so easy, and it’s not as important as these lives are (nuclear is powerful; my uncle explained that to me many, many years ago, the power and that was 35 years ago; he would explain the power of what's going to happen and he was right—who would have thought?), but when you look at what's going on with the four prisoners—now it used to be three, now it’s four—but when it was three and even now, I would have said it's all in the messenger; fellas, and it is fellas because, you know, they don't, they haven’t figured that the women are smarter right now than the men, so, you know, it’s gonna take them about another 150 years—but the Persians are great negotiators, the Iranians are great negotiators, so, and they, they just killed, they just killed us."
Terrific.
___

More to come...